Immunohistochemical studies of stellate cells in experimental cholestasis in newborn and adult rats

Clinics

Volumn 63, Issue 5, 2008, Pages 689-694

  Gibelli, Nelson Elias Mendes ^a   Tannuri, Uenis ^a   De Mello, Evandro Sobroza ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biliary atresia; Biliary congenital disorders; Experimental cholestasis; Liver fibrogenesis; Pediatric disorders; Pediatric liver disease

Indexed keywords

ACTIN; BIOLOGICAL MARKER; DESMIN; SCLEROPROTEIN; SMOOTH MUSCLE ACTIN, RAT;

AGE; ANIMAL; ARTICLE; BILE DUCT ATRESIA; CHOLESTASIS; DISEASE MODEL; FEMALE; FIBROBLAST; ITO CELL; LIGATION; MALE; NEWBORN; PATHOLOGY; PORTAL VEIN; RAT; WISTAR RAT;

ACTINS; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BILIARY ATRESIA; BIOLOGICAL MARKERS; CHOLESTASIS; DESMIN; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; HEPATIC STELLATE CELLS; LIGATION; MALE; PORTAL SYSTEM; RATS; RATS, WISTAR;

EID: 54349126428     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000500019     Document Type: Article

References (26)

1. Mann DA, Mann J. Epigenetic regulation of hepatic stellate cell activation. J Gastroenterol Hepatol. 2008;23(Suppl 1):S108-111.
2. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis. 2001;21:437-51.
3. Abdel-Aziz G, Rescan PY, Clement B, Lebeau G, Rissel M, Grimaud JA, et al. Cellular sources of matrix proteins in experimentally induced cholestatic rat liver. J Hepatol. 1991;164:167-74.
4. Ramm GA, Nair VG, Bridle KR, Shepherd RW, Crawford DH. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol. 1998;153:527-35.
5. Maher JJ, McGuire R. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal andothelial cells during hepatic fibrosis in vivo. J Clin Invest. 1990;86:1641-48.
6. Hautekeete ML, Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch. 1997;430:195-207.
7. Tao LH, Toi M, Naruse K, et al. Ito cell's migration into fibrous areas is an essential prerequisite to their myofibroblastic transformation. J Gastroenterol Hepatol. 2000;15(Suppl ):F59.
8. Hellerbrand C, Wang SC, Tsukamoto H, Brenner DA, Rippe RA. Expression of intercellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology. 1996;24:670-6.
9. Kinnman N, Goria O, Wendum D, Gendron MC, Rey C, Poupon R, et al. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury. Lab Invest 2001;81:1709-16.
10. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J Hepatol.1999;31:1120-30.
11. Maher JJ. Interations between hepatic stellate cells and the immune system. Semin Liver Dis. 2001;21:417-26.
12. Yokoi Y, Namihisa T, Hiroyuki K, Komatsu I, Miyazaki A, Watanabe S. Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology. 1984;4:709-14.
13. Ballardini G, Groff P, De Giorgi LB, Schuppan D, Bianchi FB. Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology. 1994;19:440-446.
14. Ballardini G, Fallani M, Biagini G, Bianchi FB, Pisi E. Desmin and actin in the identification of Ito cells and monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol. 1988;56:45-9.
15. Burt AD, Robertson JL, Heir J, Macsween RNM. Desmin-containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury. J Pathol. 1986;150:29-35.
16. Schmitt-Gräff A, Krüger S, Bochard F, Gabbiani G, Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and disease human livers. Am J Pathol. 1991;138:1233-42.
17. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002; 36: 200-209.
18. Tuchweber B, Desmouliére A, Bochaton-Piallat ML, Rubbia-Brandt L, Gabbiani G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest.1996;74:265-78.
19. Gibelli NE, Tannuri U, de Mello ES, Rodrigues CJ. Bile duct ligation in neonatal rats: Is it a valid experimental model for biliary atresia studies? Pediatr Transpl 2008; Apr 28 [Epub ahead of print].
20. Tannuri AC, Tannuri U, Coelho MC, Santos NA, Mello ES. Experimental models of hepatectomy and liver regeneration using newborn and weaning rats. Clinics. 2007;62:757-62
21. Desmoulière A, Darby I, Costa AMA, Raccurt M, Tuchweber B, Sommer P, et al. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest 1997;76:765-78.
22. Cameron GR, Oakley CL. Ligation of the common bile duct. J Pathol Bact. 1932;35:769-98.
23. Chou ST, Gibson JB. A histochemical study of the bile ducts in long-term biliary obstruction in the rat. J Pathol 1971; 103: 163-175.
24. Schaffner F, Bacchin PG, Hutterer F, Scharnbeck HH, Sarkozi LL, Denk H, et al. Mechanism of cholestasis: structural and biochemical changes in the liver and rats after bile duct ligation. Gastroenterology. 1971;60:888-97.
25. Johnstone JMS, Lee EG. A quantitative assessment of the structural changes in the rat's liver following obstruction of the common bile duct. Br J Exp Pathol. 1976;57:85-94.
26. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984; 65:305-11.